Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Qu J, Liao YH, Kou ZZ, Wei YY, Huang J, Chen J, Yanagawa Y, Wu SX, Shi M, Li YQ
They are part of treatment
We work directly with compounding pharmacies to avoid the markup
Semaglutide is an injectable medication originally developed for type 2 diabetes, now FDA-approved for chronic weight management
Because IGF-1 LR3 has no FDA pathway and is sold only as a "research chemical," there is no mandatory COA standard, no USP monograph, and no enforcement of purity claims
For people with type 2 diabetes, stopping without medical guidance risks hyperglycaemia and serious complications including hyperosmolar hyperglycaemic state
US$ 25.13
US$ 28.09
US$ 21.58
US$ 27.52
US$ 20.93
US$ 21.34
US$ 26.42
